Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.49 AUD | -1.01% | +22.50% | +139.02% |
May. 29 | Euroz Hartleys Adjusts Dimerix’s Price Target to AU$0.86 From AU$0.80, Keeps at Speculative Buy | MT |
May. 27 | Dimerix Signs License Deal for Kidney Disease Medication in the Middle East | MT |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Nina Webster
CEO | Chief Executive Officer | - | 18-08-26 |
Hamish George
DFI | Director of Finance/CFO | - | 19-05-05 |
David Fuller
CTO | Chief Tech/Sci/R&D Officer | - | 23-10-22 |
Robert Shepherd
PRN | Corporate Officer/Principal | - | 17-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Nina Webster
CEO | Chief Executive Officer | - | 18-08-26 |
Hugh Alsop
BRD | Director/Board Member | - | 17-04-30 |
Mark Diamond
CHM | Chairman | - | 23-01-11 |
Sonia Maria Poli
BRD | Director/Board Member | 59 | 15-07-02 |
Clinton Snow
BRD | Director/Board Member | - | 23-04-30 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 426,177,054 | 408,172,806 ( 95.78 %) | 0 | 95.78 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+139.02% | 181M | |
+46.19% | 55.7B | |
-6.14% | 39.57B | |
+39.33% | 39.91B | |
-6.65% | 28.16B | |
+12.33% | 26.3B | |
-21.78% | 18.94B | |
-0.35% | 12.12B | |
+24.18% | 12.12B | |
+28.38% | 12.17B |
- Stock Market
- Equities
- DXB Stock
- Company Dimerix Limited